In Vitro Modeling of Alcohol-Induced Liver Injury using Human-Induced Pluripotent Stem Cells

Methods in Molecular Biology

Volumn 1353, Issue , 2016, Pages 271-283

  Tian, Lipeng ^a   Prasad, Neha ^a   Jang, Yoon Young ^a  

^a NONE

Author keywords

Alcoholic liver disease; Apoptosis; Hepatic differentiation; Induced pluripotent stem cells; Liver steatosis

Indexed keywords

ALCOHOL; ALPHA FETOPROTEIN; 6 [[2 [[4 (2,4 DICHLOROPHENYL) 5 (4 METHYL 1H IMIDAZOL 2 YL) 2 PYRIMIDINYL]AMINO]ETHYL]AMINO]NICOTINONITRILE; ACTIVIN; ACTIVIN A; AZO COMPOUND; BIOLOGICAL MARKER; COLLAGEN; DRUG COMBINATION; FAT DROPLET; INSULIN; LAMININ; MATRIGEL; OIL RED O; PROTEOGLYCAN; PYRIDINE DERIVATIVE; PYRIMIDINE DERIVATIVE; SIGNAL PEPTIDE;

ALCOHOL LIVER CIRRHOSIS; APOPTOSIS; CELL DIFFERENTIATION; CELL PROLIFERATION; CELL STRUCTURE; CELL VIABILITY; CONTROLLED STUDY; ENDODERM; HEPATIC PROGENITOR CELL; HUMAN; HUMAN CELL; HUMAN CELL CULTURE; HUMAN TISSUE; IN VITRO STUDY; LIPID STORAGE; LIVER CELL; LIVER CELL DAMAGE; PLURIPOTENT STEM CELL; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; ALCOHOL LIVER DISEASE; BIOLOGICAL MODEL; CELL SURVIVAL; CHEMISTRY; CYTOLOGY; DRUG COMBINATION; DRUG EFFECTS; GENE EXPRESSION; GENETICS; INDUCED PLURIPOTENT STEM CELL; METABOLISM; NUCLEAR REPROGRAMMING; PATHOLOGY; PRIMARY CELL CULTURE;

ACTIVINS; APOPTOSIS; AZO COMPOUNDS; BIOMARKERS; CELL DIFFERENTIATION; CELL SURVIVAL; CELLULAR REPROGRAMMING; COLLAGEN; DRUG COMBINATIONS; ETHANOL; GENE EXPRESSION; HEPATOCYTES; HUMANS; INDUCED PLURIPOTENT STEM CELLS; INSULIN; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; LAMININ; LIPID DROPLETS; LIVER DISEASES, ALCOHOLIC; MODELS, BIOLOGICAL; PRIMARY CELL CULTURE; PROTEOGLYCANS; PYRIDINES; PYRIMIDINES;

EID: 84946762237     PISSN: 10643745     EISSN: None     Source Type: Book Series    
DOI: 10.1007/7651_2014_168     Document Type: Chapter

References (21)

1. Daldrup-Link HE, Nejadnik H (2014) MR imaging of stem cell transplants in arthritic joints. J Stem Cell Res Ther 4(2):165. doi:10.4172/2157-7633.1000165
2. Altamirano J, Bataller R (2011) Alcoholic liver disease: pathogenesis and new targets for therapy. Nat Rev Gastroenterol Hepatol 8 (9):491-501.doi:10.1038/nrgastro.2011.134
3. Tilg H, Day CP (2007) Management strategies in alcoholic liver disease. Nat Clin Pract Gastroenterol Hepatol 4(1):24-34. doi:10.1038/ncpgasthep0683
4. Hofer R, Burd L (2009) Review of published studies of kidney, liver, and gastrointestinal birth defects in fetal alcohol spectrum disorders. Birth Defects Res A Clin Mol Teratol 85 (3):179-183. doi:10.1002/bdra.20562
5. Lefkowitch JH, Rushton AR, Feng-Chen KC (1983) Hepatic fibrosis in fetal alcohol syndrome. Pathologic similarities to adult alcoholic liver disease. Gastroenterology 85 (4):951-957
6. Buts JP, Sokal EM, Van Hoof F (1992) Prenatal exposure to ethanol in rats: effects on postnatal maturation ofthe small intestine and liver. Pediatr Res 32(5):574-579. doi:10.1203/00006450-199211000-00018
7. Kockaya EA, Akay MT (2006) Histological changes in the liver offetuses ofalcohol-treated pregnant rats. Cell Biochem Funct 24 (3):223-227. doi:10.1002/cbf.1215
8. Bataller R, North KE, Brenner DA (2003) Genetic polymorphisms and the progression of liver fibrosis: a critical appraisal. Hepatology 37 (3):493-503.doi:10.1053/jhep.2003.50127
9. Gao B, Bataller R (2011) Alcoholic liver disease: pathogenesis and new therapeutic targets. Gastroenterology 141(5):1572-1585. doi:10.1053/j.gastro.2011.09.002
10. Neff GW, Duncan CW, Schiff ER (2011) The current economic burden of cirrhosis. Gastroenterol Hepatol 7(10):661-671
11. Siegmund SV, Dooley S, Brenner DA (2005) Molecular mechanisms of alcohol-induced hepatic fibrosis. Dig Dis 23(3-4):264-274. doi:10.1159/000090174
12. Weber SN, Wasmuth HE (2010) Liver fibrosis: from animal models to mapping of human risk variants. Best Pract Res Clin Gastroenterol 24 (5):635-646.doi:10.1016/j.bpg.2010.07.013
13. Choi SM, Liu H, Chaudhari P, Kim Y, Cheng L, Feng J, Sharkis S, Ye Z, Jang YY (2011) Reprogramming of EBV-immortalized B-lymphocyte cell lines into induced pluripo-tent stem cells. Blood 118(7):1801-1805. doi:10.1182/blood-2011-03-340620
14. Liu H, Kim Y, Sharkis S, Marchionni L, Jang YY (2011) In vivo liver regeneration potential of human induced pluripotent stem cells from diverse origins. Sci Transl Med 3(82):82ra39. doi:10.1126/scitranslmed.3002376
15. Liu H, Ye Z, Kim Y, Sharkis S, Jang YY (2010) Generation of endoderm-derived human induced pluripotent stem cells from primary hepatocytes. Hepatology 51(5):1810-1819. doi:10.1002/hep.23626
16. Yu J, Vodyanik MA, Smuga-Otto K, Antosiewicz-Bourget J, Frane JL, Tian S, Nie J, Jonsdottir GA, Ruotti V, Stewart R, Slukvin II, Thomson JA (2007) Induced pluripotent stem cell lines derived from human somatic cells. Science 318(5858):1917-1920. doi:10.1126/science.1151526
17. Choi SM, Kim Y, Shim JS, Park JT, Wang RH, Leach SD, Liu JO, Deng C, Ye Z, Jang YY (2013) Efficient drug screening and gene correction for treating liver disease using patient-specific stem cells. Hepatology 57(6): A2458-2468. doi:10.1002/hep.26237
18. Choi SM, Kim Y, Liu H, Chaudhari P, Ye Z, Jang YY (2011) Liver engraftment potential of hepatic cells derived from patient-specific induced pluripotent stem cells. Cell Cycle 10 (15):2423-2427
19. Dolganiuc A, Szabo G (2009) In vitro and in vivo models of acute alcohol exposure. World J Gastroenterol 15(10):1168-1177
20. Szabo G, Mandrekar P (2008) Human monocytes, macrophages, and dendritic cells: alcohol treatment methods. Methods Mol Biol 447:113-124. doi:10.1007/978-1-59745-242-7_9
21. Miranda RC, Santillano DR, Camarillo C, Dohrman D (2008) Modeling the impact of alcohol on cortical development in a dish: Strategies from mapping neural stem cell fate. Methods Mol Biol 447:151-168. doi:10.1007/978-1-59745-242-7_12